SeaStar Medical Holding Corporation carries a market capitalization of 821,874.00, placing it among publicly traded companies globally. Its enterprise value stands at -9.02M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 821,874.00 |
| Enterprise Value | -9.02M |
SeaStar Medical Holding Corporation currently has 3.99M shares outstanding.
| Shares Outstanding | 3.99M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
SeaStar Medical Holding Corporation maintains a current ratio of 2.73, meaning it holds 2.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 4.52, indicating elevated leverage, while an interest coverage ratio of -426.93 demonstrates limited ability to service its debt obligations.
| Current Ratio | 2.73 |
| Quick Ratio | 2.41 |
| Debt / Equity | 4.52 |
| Debt / EBITDA | -0.03 |
| Interest Coverage | -426.93 |
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -126.18 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 1.96 |
| Income Tax | 3,000.00 |
| Effective Tax Rate | N/A |
SeaStar Medical Holding Corporation's stock has declined approximately -17.98561% over the past 52 weeks. The 50-day moving average sits at 0.02, while the 200-day moving average is 0.03.
| Beta (5Y) | N/A |
| 52-Week Price Change | -17.98561% |
| 50-Day Moving Average | 0.02 |
| 200-Day Moving Average | 0.03 |
| Average Volume (20 Days) | N/A |
EBITDA reached -11.95M, while operating income came in at -11.95M.
| Revenue | 1.44M |
| Gross Profit | 1.34M |
| Operating Income | -11.95M |
| Pretax Income | -11.90M |
| Net Income | -11.90M |
| EBITDA | -11.95M |
| EBIT | -11.95M |
| Earnings Per Share (EPS) | N/A |
SeaStar Medical Holding Corporation holds 9.35M in cash and equivalents against 331,000.00 in total debt, resulting in a net debt position of -9.02M. Total book value stands at -155.23M, with working capital of 6.82M providing operational flexibility.
| Cash & Cash Equivalents | 9.35M |
| Total Debt | 331,000.00 |
| Net Debt | -9.02M |
| Equity (Book Value) | -155.23M |
| Book Value Per Share | N/A |
| Working Capital | 6.82M |
SeaStar Medical Holding Corporation produced -13.71M in operating cash flow over the past twelve months.
| Operating Cash Flow | -13.71M |
| Capital Expenditures | N/A |
| Free Cash Flow | -13.71M |
| FCF Per Share | N/A |
SeaStar Medical Holding Corporation operates with a gross margin of 93.11, reflecting its pricing power and cost economics. The operating margin of -832.45 and net profit margin of -828.62 provide insight into operational efficiency.
| Gross Margin | 93.11 |
| Operating Margin | -832.45 |
| Pretax Margin | -828.41 |
| Profit Margin | -828.62 |
| EBITDA Margin | -832.45 |
SeaStar Medical Holding Corporation posts an Altman Z-Score of -21.94, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -21.94 |